Pressure of Truth
Exposing the spin on all sides of the news.

Finance

Developing

Reuters Reports Anthropic's IPO Marketing Pushed to Mid-October at the Earliest

People familiar with the plans told Reuters the prospectus will now come out in late September and investor marketing in mid-October; some investors have floated a valuation above $2 trillion, a figure Anthropic has not confirmed.

Sep 6, 2026 · 15 sources cited · ✓ fact-checked
Developing

Nvidia Confirms $12.9 Billion Deal to Buy AI Model Platform Hugging Face

Nvidia says it will pay about $11.9 billion to Hugging Face shareholders plus roughly $1 billion in retention equity, in a deal it expects to close in the first half of 2027 pending regulatory review.

Sep 6, 2026 · 20 sources cited · ✓ fact-checked
Developing

Bitcoin Tops $81,000 for the First Time in Nearly Four Months; Coinbase and Strategy Shares Rise

The move is a third straight weekly gain off a June low near $63,000, and still leaves bitcoin roughly 35% below its October 2025 record, as traders watch fading Fed rate-hike odds and a Senate crypto bill.

Sep 5, 2026 · 21 sources cited · ✓ fact-checked
Developing

Lululemon Cuts Full-Year Revenue Outlook to $10.35–$10.5 Billion; Shares Fall About 18% to Below $100

The company reported a 9% drop in comparable sales and diluted earnings of $2.92 a share, a figure that included a benefit from tariff refunds, and lowered its fiscal 2026 revenue and profit forecasts for the third time this year.

Sep 5, 2026 · 17 sources cited · ✓ fact-checked

Oura Files S-1 for Nasdaq Listing, Reporting $1.21 Billion in Revenue for the Nine Months Ended June 30, 2026

The Finland-founded smart-ring maker plans to trade as OURA and disclosed 5.0 million paid members, a $985.0 million deemed dividend to preferred holders, and the U.S. Department of Defense as its largest enterprise customer.

Sep 5, 2026 · 0 sources cited · ✓ fact-checked
Developing

NHTSA Opens Audit Into Tesla's Cybercab Safety Certification a Day After Austin Launch; Tesla Shares Fall 6%

Tesla began paid Cybercab rides in Austin on Sept. 3 without disclosing fleet targets or pricing; federal regulators opened Audit Query AQ26002 covering about 1,000 vehicles the next day.

Sep 5, 2026 · 16 sources cited · ✓ fact-checked
Developing

BLS Releases August Employment Report Friday as Fed Officials Debate a Rate Increase at the Sept. 15-16 Meeting

Forecasters going into the 8:30 a.m. release expected roughly 53,000 to 58,000 new jobs and an unemployment rate near 4.1%, while Fed Chair Kevin Warsh has pointed to inflation as the bigger worry.

Sep 4, 2026 · 17 sources cited · ✓ fact-checked

Broadcom Reports $29.6 Billion in Quarterly Revenue, Up 86%; Shares Close Down 3.4% After $34.8 Billion Guidance

The chipmaker beat analyst estimates for the quarter ended Aug. 2 and said AI chip sales rose 221% to $16.7 billion, while its fourth-quarter revenue forecast came in roughly $200 million below the Wall Street consensus.

Sep 4, 2026 · 13 sources cited · ✓ fact-checked
Developing

Fed Governor Waller Says He Could Back Holding Rates Steady If the Sept. 11 Inflation Report Shows Cooling

Waller's Sept. 3 remarks set a data condition for the Sept. 15-16 policy meeting and read as less hawkish than Chair Kevin Warsh's Aug. 28 Jackson Hole speech; futures pricing for a rate increase fell toward a coin flip.

Sep 4, 2026 · 20 sources cited · ✓ fact-checked
Developing

ADP Reports 38,000 Private-Sector Jobs Added in August; Weekly Jobless Claims at 206,000

Two labor readings landed days before the Federal Reserve's Sept. 16-17 meeting, where Chair Kevin Warsh's hawkish inflation stance has collided with pressure from the Trump administration and rate-cut-leaning forecasters.

Sep 3, 2026 · 15 sources cited · ✓ fact-checked

Dell Reports $47.0 Billion in Quarterly Revenue and a $95 Billion AI-Server Backlog, Raises Full-Year Outlook to $192 Billion

Dell Technologies said fiscal second-quarter revenue rose 58% and beat analyst estimates, while analysts continue to debate whether the AI-server orders can be built and shipped profitably.

Sep 2, 2026 · 16 sources cited · ✓ fact-checked

Eli Lilly to Buy Merida Biosciences for Up to $2.875 Billion in Cash

The Cambridge, Massachusetts biotech's lead drug, MER511, is in Phase 1 testing for Graves' disease and thyroid eye disease; Lilly says the deal should close in the fourth quarter of 2026.

Sep 2, 2026 · 15 sources cited · ✓ fact-checked